Over 3 years (FY 2021 to FY 2024), CapEx shows a downward trend with a -100.0% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.42M | $312.00K | $4.00K | $0.00 | $75.00K | $62.00K | $85.00K | $26.00K | $3.00K | $8.00K | -$74.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$168.00K |
| QoQ Change | — | -78.0% | -98.7% | -100.0% | — | -17.3% | +37.1% | -69.4% | -88.5% | +166.7% | <-999% | +100.0% | — | — | — | — | — |
| YoY Change | — | — | — | — | -94.7% | -80.1% | >999% | — | -96.0% | -87.1% | -187.1% | -100.0% | -100.0% | -100.0% | +100.0% | — | — |